Skip to main content
OpenTrials
Completed

NCT Number: NCT05276778

Diabetic Retinopathy Screening in General Practice

Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce the risk of sight loss since the disease can be treated if detected in time. For people with type 2 diabetes, retinopathy screenings are typically performed by specialist at private ophthalmologists' practices, and individualized screening intervals based on retinopathy level and diabetes regulation are recommended. Unfortunately, 26% of people with type 2 diabetes do not follow their screening interval, and the attendance is too low compared to the national standard of minimum 90% of patients with diabetes who ought to follow the screening program. Consequently, actions must be taken to improve screening attendance in Denmark.

The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with type 2 diabetes
  • Understands Danish
  • Age between 18-70

Exclusion criteria

  • Blindness
  • Cannot partake in second screening

Treatment and study plan

Diabetic Retinopathy Screening

Diagnostic Test

Screenings are performed in the diabetes consultation in general practice

Primary outcomes

  1. Patients' acceptance of diabetic retinopathy screenings in general practice

    Time frame: 1 day (the questionnarie is fufilled one time after the retinopaty screening in general practice)

    Questionnaire

Sponsors and collaborators

Lead sponsor

Aalborg University

Other

Registry information

Official study title

Diabetic Retinopathy Screenings in General Practice for People With Type 2 Diabetes

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Mar 11, 2022
Registry last updated
May 6, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.